GLN-OLMESARTAN HCTZ

glenmark pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Id: 98c9877ac7adaf79
Drug Approval Canada Name: GLN-OLMESARTAN HCTZ
Product Name: GLN-OLMESARTAN HCTZ
Status: Marketed
Status Date: 2020-02-28
Original Market Date: 2020-02-28
Din: 02475707
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 40:28.20
Atc Original: C09DA08 OLMESARTAN MEDOXOMIL AND DIURETICS
Atc Name: c 09 da 08
Aig Number: 0252502001
Company Name: glenmark pharmaceuticals canada inc.
Company Address: 1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2

HYDROCHLOROTHIAZIDE

12.5 MG

OLMESARTAN MEDOXOMIL

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

98c9877ac7adaf79

Type

Standard